147 related articles for article (PubMed ID: 19716599)
1. UPLIFTing care for chronic obstructive pulmonary disease.
Davies L; Calverley PM
Lancet; 2009 Oct; 374(9696):1129-30. PubMed ID: 19716599
[No Abstract] [Full Text] [Related]
2. COPD and declining FEV1--time to divide and conquer?
Reilly JJ
N Engl J Med; 2008 Oct; 359(15):1616-8. PubMed ID: 18836214
[No Abstract] [Full Text] [Related]
3. Tiotropium in chronic obstructive pulmonary disease.
Chang ET
N Engl J Med; 2009 Jan; 360(2):185; author reply 187. PubMed ID: 19137623
[No Abstract] [Full Text] [Related]
4. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
5. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium in chronic obstructive pulmonary disease.
O'Connor AB
N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624
[No Abstract] [Full Text] [Related]
7. After UPLIFT: smoking cessation remains the best intervention in smokers with COPD.
Chen-Yuan C
Int J Tuberc Lung Dis; 2009 Feb; 13(2):151-2. PubMed ID: 19146740
[No Abstract] [Full Text] [Related]
8. [Tiotropium--the "surgical" drug].
Mihălţan F
Pneumologia; 2004; 53(4):189-92. PubMed ID: 16106727
[No Abstract] [Full Text] [Related]
9. Family increases: UPLIFT first maintenance subgroup analysis.
Puente-Maestú L; De Miguel J
Eur Respir J; 2010 Jul; 36(1):10-1. PubMed ID: 20595162
[No Abstract] [Full Text] [Related]
10. Uplifting times for COPD.
Halpin DM
Prim Care Respir J; 2008 Dec; 17(4):197-8. PubMed ID: 18972060
[No Abstract] [Full Text] [Related]
11. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
12. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
[No Abstract] [Full Text] [Related]
13. [Tiotropium in asthma--a new opportunity?].
Mihălţan F; Ulmeanu R
Pneumologia; 2014; 63(4):200-2. PubMed ID: 25665363
[TBL] [Abstract][Full Text] [Related]
14. New therapy for managing moderate to severe chronic obstructive pulmonary disease.
Chou A; D'Urzo AD
Can Fam Physician; 2014 Apr; 60(4):352-4. PubMed ID: 24733327
[No Abstract] [Full Text] [Related]
15. Tiotropium-lessons from recent studies.
Black PN
Respirology; 2009 Jul; 14(5):623-4. PubMed ID: 19659644
[No Abstract] [Full Text] [Related]
16. Four-year trial of tiotropium in chronic obstructive pulmonary disease.
D'Urzo AD; Jugovic P; Jhirad R; Bouchard J
Can Fam Physician; 2012 Aug; 58(8):848-9. PubMed ID: 22893337
[No Abstract] [Full Text] [Related]
17. How much lift to the UPLIFT study?
Mohapatra PR
Lancet; 2010 Jan; 375(9710):197-8; author reply 198. PubMed ID: 20109917
[No Abstract] [Full Text] [Related]
18. [Early diagnosis, Uplift and COPD in stage II].
Mihălţan F; Ulmeanu R
Pneumologia; 2009; 58(4):263-5. PubMed ID: 20067063
[No Abstract] [Full Text] [Related]
19. Triple inhaler therapy for COPD.
Lipworth B
Thorax; 2015 Oct; 70(10):991. PubMed ID: 26092923
[No Abstract] [Full Text] [Related]
20. Complete smoking cessation is beneficial in older and more advanced COPD patients.
Zielinski J; Bednarek M; Gorecka D
Eur Respir J; 2010 Jul; 36(1):216-7; author reply 217-8. PubMed ID: 20595173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
